Branded GLP-1 pricing in 2026 runs on two separate ledgers that most programs quietly merge into one. What Wegovy, Zepbound and Ozempic cost is the medicine's price, set by the manufacturer and collected by the pharmacy. The care has a price set by the practice. When those two are bundled into a single monthly subscription, the patient cannot see what either one costs, which is exactly where dose upcharges, molecule upcharges and repricing live. This guide lays out those self-pay prices in 2026, who sets each number and how a flat-fee membership treats both ledgers separately.

Key takeaways
  • Zepbound self-pay commonly reports $299 to $449 a month by dose through LillyDirect in 2026, with lower doses at the lower end.
  • Wegovy self-pay commonly reports $499 a month through NovoCare.
  • Ozempic self-pay commonly reports around $499 a month, though its approved indication is type 2 diabetes rather than weight loss.
  • The manufacturer sets the price and the pharmacy collects it and any clinic that marks it up adds a third party to the transaction.
  • Our membership fee is a flat $299 a month for the doctor and the quarterly Biomarker Audit and it never rises with the dose.

The two ledgers, stated plainly

The first ledger is the medicine. The manufacturer sets a self-pay price, the pharmacy collects it and no honest intermediary should stand between those two parties. When a program marks the medication up, every dose escalation and every molecule switch becomes a revenue event and the patient has no way to see the markup because the invoice arrives as one number.

The second ledger is the care. The clinical relationship, the quarterly Biomarker Audit, the prescribing and the follow-up have their own cost and bundling them into the medication subscription is how the industry has historically justified rising prices as doses rise. We keep them separate on purpose. One flat fee for the doctor. Zero markup on the medicine.

What each branded medication costs in 2026

Prices move and each manufacturer publishes its own self-pay route, so treat every figure here as the commonly reported range as of 2026 and verify at the source before you budget.

Zepbound, the tirzepatide pen from Eli Lilly for weight loss and obstructive sleep apnea, is available through LillyDirect self-pay vial pricing commonly reported between $299 and $449 a month depending on dose, with lower doses at the lower end of the range. Because the price is dose-tiered, a successful step-down after goal weight lowers the pharmacy bill automatically.

Wegovy, the semaglutide pen from Novo Nordisk for weight loss and cardiovascular risk reduction, is available through NovoCare self-pay commonly reported around $499 a month.

Ozempic, the semaglutide pen for type 2 diabetes, is commonly reported around $499 a month on the self-pay market as well. For cash-pay weight loss patients the relevant product is usually Zepbound or Wegovy, because Mounjaro and Ozempic carry diabetes indications and cash-pay patients are routed to the weight loss brands. Zepbound and Mounjaro are the same molecule, tirzepatide and Wegovy and Ozempic are the same molecule, semaglutide.

Branded self-pay prices, commonly reported 2026

MedicationMoleculeSelf-pay priceSelf-pay route
ZepboundTirzepatide$299 to $449 a month by doseLillyDirect
WegovySemaglutide~$499 a monthNovoCare
OzempicSemaglutide~$499 a monthNovoCare
MounjaroTirzepatideVaries, insurance-routedInsurance for type 2 diabetes

Where the price actually goes

A useful test for any program is asking who touches the medication price between the manufacturer and you. In our model the answer is nobody. The pharmacy bills you directly at the manufacturer's self-pay price and we take nothing from that transaction, because the membership fee covers the clinical layer and the two ledgers never merge.

That structure has a consequence patients care about more than they expect. When your dose changes, your pharmacy bill changes and our fee does not. When you switch molecules, your pharmacy bill changes and our fee does not. When you reach goal weight and step down, your pharmacy bill falls and our fee stays flat. A bundled subscription cannot make any of those promises honestly, because its revenue sits inside the medication price.

GoodLife Health. Medicine that builds on itself, $299 a month: 90-day labs, your clinician, branded GLP-1s, one platform. See if you qualify.GoodLife Health. $299 a month. Everything talks to everything: quarterly labs read by your clinician, branded GLP-1s prescribed from them, every result and dose tracked on one platform. See if you qualify.

The full year in money

Budget honesty means seeing both ledgers together, which is why we put the math on one page rather than revealing the second number at checkout. Twelve months in the membership comes to $3,588, which is the $598 first charge covering the first two months plus ten months at $299. Twenty-four months comes to $7,176 and includes eight quarterly Biomarker Audits across the two years.

On top of that sits the pharmacy ledger at whatever dose your clinician lands on. A year of Zepbound at a mid-tier dose commonly reports around $3,588 to $5,388 on the self-pay market and a year of Wegovy commonly reports around $5,988. Those numbers are the pharmacy's, not ours and they move with dose and with manufacturer pricing. We would rather show you both ledgers on one page than let you discover the second one after you commit.

Why compounded copies are cheaper and what that price hides

Compounded copies of semaglutide and tirzepatide commonly report below the branded prices and the gap is the business model. A copy is cheaper to source, carries no trial evidence and no manufacturing oversight of the kind the branded pens carry and the FDA has documented dosing errors, contamination and salt-form substitutions in some compounded GLP-1 products. The shortage that once justified compounding has largely resolved, so a clinic still selling a copy today is usually choosing it for margin rather than supply. We prescribe branded and FDA-approved medication only and we bill it at the pharmacy's own price, which means we cannot compete with a copy on price and we do not try.

What the membership fee covers and what it never covers

The $299 monthly fee covers the clinical relationship: your physician or clinician of record, the quarterly Biomarker Audit with the full metabolic, lipid, inflammation, hormone and thyroid panels, the prescribing decisions and the follow-up between audits. It has no tiers and it never changes with the prescription, because the medication is a separate charge billed by the pharmacy at pharmacy cost.

Clinical care is delivered by physicians of Beluga Health, P.A., an independent Florida professional corporation licensed in all 50 states, working under GoodLife Health's clinical protocols. All labs run through the Beluga Health lab network and additional labs beyond the quarterly cadence are billed to you at pass-through cost.

The objections a cash-pay patient raises, answered

"These prices are higher than the compounded ads I see." They are and the gap is the point. A compounded copy carries no trial evidence, no manufacturing oversight of the kind the branded pens carry and a documented history of dosing errors and salt-form substitutions at some facilities. The branded price buys the molecule the trials were run on and the trials are the only reason anyone knows what these medications actually do. We prescribe branded and FDA-approved medication only and we say plainly that we cannot compete with a copy on price.

"Why does the membership fee exist at all if the medication is separate?" Because the clinical layer is real work and it deserves its own honest price rather than being hidden inside a medication markup. The fee buys the physician relationship, the quarterly Biomarker Audit with the full panel, the prescribing decisions and the follow-up between audits and pricing it flat means the fee never rises with the dose, the molecule or the year of treatment.

"What if I only want the medication without the membership?" Then we are probably not the right program and it is better to say so than to pretend otherwise. The prescribing in our model is inseparable from the labs that justify it and a prescription without measurement is the failure mode this whole guide is written against. Patients who want the medication alone have options we would rather point to honestly than approximate with a stripped-down version of the membership.

"Will the manufacturer prices stay where they are?" Nobody can promise that and we will not pretend to. What we can promise is that whatever the manufacturer does flows through the pharmacy to you and nowhere else, because our fee is set by the membership and our revenue never touches the medication transaction.

FAQ

How much does Zepbound cost without insurance in 2026? LillyDirect self-pay vial pricing commonly reports between $299 and $449 a month depending on dose, with lower doses at the lower end. Your pharmacy bills that price directly and we add nothing to it.

How much does Wegovy cost without insurance in 2026? NovoCare self-pay commonly reports around $499 a month. Verify the current price at the manufacturer's page before you budget, because published pricing moves.

Does the GoodLife Health membership fee include the medication? No and we are explicit about it. The flat $299 monthly fee covers the doctor and the quarterly Biomarker Audit. The medication is a separate charge billed by the pharmacy at its own price with zero markup, no molecule upcharge and no dose escalation fee.

What does a full year cost with both ledgers? Twelve months in the membership comes to $3,588, the $598 first charge plus ten months at $299. The pharmacy ledger sits on top at whatever dose your clinician lands on, commonly reported between $299 and $599 a month by molecule and dose.

Why is compounded semaglutide cheaper? Because it is a copy without the branded product's trial evidence, manufacturing oversight or regulatory scrutiny and because the clinic's margin usually lives in the markup. We prescribe branded and FDA-approved medication only.

Do you mark up the medication price? No. The pharmacy bills you directly at the manufacturer's self-pay price and our revenue never touches that transaction. When your dose falls your pharmacy bill falls and our fee does not move.

What happens if a manufacturer changes its price? The change flows through the pharmacy to you and nowhere else. We set no medication price and take nothing from it, so a manufacturer increase or decrease changes your bill and never our fee.

Related Guides

References

  1. LillyDirect Zepbound self-pay pricing, Eli Lilly. lilly.com
  2. NovoCare self-pay pharmacy, Novo Nordisk. novocare.com
  3. FDA concerns with compounded semaglutide. fda.gov
  4. STEP-1: Once-Weekly Semaglutide in Adults with Overweight or Obesity, NEJM 2021. PubMed 33567185
  5. SURMOUNT-1: Tirzepatide Once Weekly for the Treatment of Obesity, NEJM 2022. PubMed 35658024